Literature DB >> 33352193

Which N Descriptor Is More Predictive of Prognosis in Resected Non-small Cell Lung Cancer: The Number of Involved Nodal Stations or the Location-Based Pathological N Stage?

Long Xu1, Hang Su1, Yunlang She1, Chenyang Dai1, Mengmeng Zhao1, Jiani Gao1, Huikang Xie2, Yijiu Ren1, Dong Xie1, Chang Chen3.   

Abstract

BACKGROUND: The eighth edition of nodal classification for non-small cell lung cancer (NSCLC) is defined only by the anatomical location of metastatic lymph nodes. RESEARCH QUESTION: We sought to evaluate the prognostic significance and discriminatory capability of the number of involved nodal stations (nS) in a large Chinese cohort. STUDY DESIGN AND METHODS: A total of 4,011 patients with NSCLC undergoing surgical resection between 2009 and 2013 were identified. The optimal cutoff values for nS classification were determined with X-tile software. Kaplan-Meier and multivariate Cox analysis were used to examine the prognostic performance of nS classification in comparison with location-based N classification. A decision curve analysis was performed to evaluate the standardized net benefit of nS classification in predicting prognosis.
RESULTS: All the patients were classified into four prognostically different subgroups according to the number of involved nodal stations: (1) nS0 (none positive), (2) nS1 (one involved station), (3) nS2 (two involved stations), and (4) nS ≥ 3 (three or more involved stations). The prognoses among all the neighboring categories of nS classification were statistically significantly different in terms of disease-free survival and overall survival. The multivariate Cox analysis demonstrated that nS was an independent prognostic factor of disease-free survival and overall survival. Patients with N1 or N2 stage disease could be divided into three prognostically different subgroups according to nS classification. However, the prognosis was similar between the N1 and N2 subgroups when patients were staged in the same nS category. The decision curve analysis showed that nS classification tended to have a higher predictive capability than location-based N classification.
INTERPRETATION: The nS classification could be used to provide a more accurate prognosis for patients with resected NSCLC. The nS is worth taking into consideration when defining nodal category in the forthcoming ninth edition of the staging system.
Copyright © 2020 American College of Chest Physicians. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  N classification; non-small cell lung cancer; number of involved nodal stations; prognosis

Year:  2020        PMID: 33352193     DOI: 10.1016/j.chest.2020.12.012

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  5 in total

1.  COVID-19 mortality in the UK Biobank cohort: revisiting and evaluating risk factors.

Authors:  Joshua Elliott; Barbara Bodinier; Paul Elliott; Marc Chadeau-Hyam; Matthew Whitaker; Cyrille Delpierre; Roel Vermeulen; Ioanna Tzoulaki
Journal:  Eur J Epidemiol       Date:  2021-02-15       Impact factor: 8.082

2.  Prognostic nomogram for predicting long-term survival in bronchopulmonary carcinoid tumor patients receiving resection.

Authors:  Qiao Li; Qichen Chen; Jinghua Chen; Zijing Wang; Pan Wang; Hong Zhao; Jun Zhao
Journal:  Ann Transl Med       Date:  2021-09

3.  A new N descriptor for non-small cell lung cancer: the classification based on anatomic location, number and ratio of metastatic lymph nodes.

Authors:  Bolun Zhou; Ruochuan Zang; Moyan Zhang; Peng Song; Lei Liu; Fenglong Bie; Yue Peng; Guangyu Bai; Shugeng Gao
Journal:  Transl Lung Cancer Res       Date:  2022-08

4.  Log odds of positive lymph nodes is a robust predictor of survival and benefits from postoperative radiotherapy in stage IIIA-N2 resected non-small cell lung cancer.

Authors:  Xing Jin; Donglai Chen; Yumei Shen; Jian Shu; Yonghua Sang; Wentao Yang; Shanzhou Duan; Yongbing Chen
Journal:  Thorac Cancer       Date:  2022-08-23       Impact factor: 3.223

5.  Risk factors for Covid-19 severity and fatality: a structured literature review.

Authors:  Dominik Wolff; Sarah Nee; Natalie Sandy Hickey; Michael Marschollek
Journal:  Infection       Date:  2020-08-28       Impact factor: 7.455

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.